Free Trial

Journey Medical (DERM) News Today

Journey Medical logo
$5.19 +0.05 (+0.97%)
Closing price 02/21/2025 04:00 PM Eastern
Extended Trading
$4.97 -0.22 (-4.14%)
As of 02/21/2025 06:39 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Journey Medical Co. stock logo
Journey Medical Co. (NASDAQ:DERM) Short Interest Update
Journey Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a significant growth in short interest during the month of January. As of January 31st, there was short interest totalling 83,800 shares, a growth of 6.5% from the January 15th total of 78,700 shares. Based on an average daily trading volume, of 80,800 shares, the days-to-cover ratio is presently 1.0 days. Currently, 0.8% of the company's stock are short sold.
Roth MKM Remains a Buy on Journey Medical Corp (DERM)
Journey Medical Co. stock logo
Short Interest in Journey Medical Co. (NASDAQ:DERM) Grows By 14.8%
Journey Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 76,800 shares, an increase of 14.8% from the December 31st total of 66,900 shares. Approximately 0.8% of the shares of the stock are short sold. Based on an average daily trading volume, of 108,900 shares, the days-to-cover ratio is presently 0.7 days.
Journey Medical Co. stock logo
Journey Medical Co. (NASDAQ:DERM) Sees Significant Increase in Short Interest
Journey Medical Co. (NASDAQ:DERM - Get Free Report) saw a significant increase in short interest in December. As of December 31st, there was short interest totalling 76,800 shares, an increase of 14.8% from the December 15th total of 66,900 shares. Based on an average daily trading volume, of 108,900 shares, the short-interest ratio is currently 0.7 days. Approximately 0.8% of the company's shares are sold short.
Journey Medical Co. stock logo
Journey Medical (NASDAQ:DERM) Shares Down 5.3% - Here's Why
Journey Medical (NASDAQ:DERM) Shares Down 5.3% - Here's What Happened
Journey Medical Co. stock logo
Journey Medical Co. (NASDAQ:DERM) Sees Large Increase in Short Interest
Journey Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a large increase in short interest in November. As of November 30th, there was short interest totalling 76,700 shares, an increase of 15.9% from the November 15th total of 66,200 shares. Currently, 0.8% of the company's stock are short sold. Based on an average trading volume of 105,000 shares, the short-interest ratio is presently 0.7 days.
Journey Medical Co. stock logo
FY2024 EPS Forecast for Journey Medical Lowered by Analyst
Journey Medical Co. (NASDAQ:DERM - Free Report) - Research analysts at Roth Capital lowered their FY2024 earnings per share estimates for Journey Medical in a note issued to investors on Monday, November 18th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings per sh
Journey Medical management to meet virtually with B. Riley
Journey Medical Co. stock logo
FY2024 EPS Estimates for Journey Medical Raised by B. Riley
Journey Medical Co. (NASDAQ:DERM - Free Report) - Stock analysts at B. Riley upped their FY2024 earnings per share (EPS) estimates for shares of Journey Medical in a research report issued to clients and investors on Monday, November 18th. B. Riley analyst K. Patel now forecasts that the company
Journey Medical Co. stock logo
Journey Medical Co. (NASDAQ:DERM) Short Interest Down 20.7% in October
Journey Medical Co. (NASDAQ:DERM - Get Free Report) was the recipient of a significant drop in short interest during the month of October. As of October 31st, there was short interest totalling 60,800 shares, a drop of 20.7% from the October 15th total of 76,700 shares. Based on an average trading volume of 88,700 shares, the short-interest ratio is currently 0.7 days. Approximately 0.6% of the company's shares are sold short.
Journey Medical Reports Q3 2024 Earnings, Eyes Emrosi Launch
Lake Street Remains a Buy on Journey Medical Corp (DERM)
Journey Medical Co. stock logo
Journey Medical FY2024 EPS Forecast Boosted by Roth Capital
Journey Medical Co. (NASDAQ:DERM - Free Report) - Investment analysts at Roth Capital boosted their FY2024 earnings per share (EPS) estimates for Journey Medical in a report released on Monday, November 4th. Roth Capital analyst J. Wittes now anticipates that the company will post earnings per sh
Journey Medical Co. stock logo
Q3 EPS Estimates for Journey Medical Decreased by Analyst
Journey Medical Co. (NASDAQ:DERM - Free Report) - Investment analysts at Roth Capital dropped their Q3 2025 EPS estimates for shares of Journey Medical in a report released on Monday, November 4th. Roth Capital analyst J. Wittes now forecasts that the company will post earnings of $0.20 per share
FDA Approves New Option for Rosacea
Biotech Stocks Facing FDA Decision In November 2024
Journey Medical Co. stock logo
Journey Medical Co. (NASDAQ:DERM) Short Interest Up 10.5% in September
Journey Medical Co. (NASDAQ:DERM - Get Free Report) was the target of a significant increase in short interest in the month of September. As of September 30th, there was short interest totalling 87,700 shares, an increase of 10.5% from the September 15th total of 79,400 shares. Approximately 0.9% of the shares of the stock are sold short. Based on an average trading volume of 55,400 shares, the days-to-cover ratio is currently 1.6 days.
Journey Medical Co. stock logo
PVG Asset Management Corp Purchases New Holdings in Journey Medical Co. (NASDAQ:DERM)
PVG Asset Management Corp acquired a new position in shares of Journey Medical Co. (NASDAQ:DERM - Free Report) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 158,540 shares of the compan
Journey Medical Corp (DERM) Gets a Buy from Lake Street
Nextech Launches Expanded Payments Functionality
Journey Medical Co. stock logo
Journey Medical Co. (NASDAQ:DERM) Shares Sold by Acadian Asset Management LLC
Acadian Asset Management LLC reduced its stake in shares of Journey Medical Co. (NASDAQ:DERM - Free Report) by 57.6% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 94,404 shares of the company
Journey Medical Co. stock logo
Journey Medical (NASDAQ:DERM) Earns Buy Rating from Analysts at Lake Street Capital
Lake Street Capital began coverage on shares of Journey Medical in a research report on Friday. They set a "buy" rating and a $9.00 price objective for the company.
Get Journey Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter.

DERM Media Mentions By Week

DERM Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

DERM
News Sentiment

0.97

0.60

Average
Medical
News Sentiment

DERM News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

DERM Articles
This Week

2

2

DERM Articles
Average Week

Get Journey Medical News Delivered to You Automatically

Sign up to receive the latest news and ratings for DERM and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:DERM) was last updated on 2/22/2025 by MarketBeat.com Staff
From Our Partners